Specials Pharma Ltd (9011403) - Improvement action plan

The pharmacy does not carry out risk assessments for the service and medicines it supplies at a distance. It has some written procedures, but it does not always follow them.

The Pharmacy has now performed a Risk Assessment both for services (RA001) and product (RA002) to ensure that current practices, SOPs and GPhC standards align. Issues were found and 2 change controls (CC001, CC002 respectively) were opened to ensure that all changes are performed and closed out.

Both Risk assessment provide a framework of objectives and then further breaks them down into a GAP analysis to provide a review of what is require, what is in place and what needs to be done.

Both Change Controls follow on from the Risk Assessments to ensure that GAPs are looked at and delivered. For this the GAP analysis is broken down into a list of deliverables and a project plan is provided with timelines of how those deliverables are managed.

RA001 – Risk Analysis Specials Pharma looks at risk posed by the service such as Regulatory and Licensing, Th e Quality Management System (QMS), patient Care, Safety and Safeguarding, Patient Confidentiality, Qualifications, documentation and staffing.

RA002 – Risk Analysis for specific controlled drugs looks at the risked posed by the product and it’s handling and looks at New patients, ID Verification, Drug Administration, Drug Information, Postage and Deliveries, Post dispensing care, disposal of goods and complaints.

Review SOP to take out ID
Verification but to include identify
the customer